Renal outcomes of SGLT2 inhibitors and GLP1 agonists in clinical practice
Patients with a history of pancreatitis or gallbladder disease also warrant careful monitoring, as GLP-1 medications have been associated with gallstones and gallbladder inflammation in some cases
Review the batch-specific certificate of analysis
If side effects are severe at a given dose, you have options
To date, none of the recalled eye drops came from major ophthalmic pharmaceutical firms
Cosmos Study June 20, 2024 Dual-Team Study Team A:Kersten Bartelt, RNTed Stamp Team B:Matthew Gracianette, MDJoe Deckert, PhD Key Findings Babies born to non-diabetic mothers prescribed glucagon-like peptide-1 receptor agonist (GLP-1) medications in the 90 days before pregnancy are 21% more likely to be admitted to the NICU than babies born to mothers not prescribed weight loss medications